Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:24:14

U.S. Science Summit: Curie.Bio Chairman Alexis Borisy...

BiotechTV - News ·

2026/07/27

Alexis Borisy recounts the story of Revolution Medicines, which delivered the pancreatic cancer breakthrough this year, and talks about the health of the founder led side of the biotech sector. Mathai Mammen recently took Parabilis public in the largest IPO in biotech history, and describes the science that made it possible.

en-us

00:24:18

U.S. Science Summit: Flagship Pioneering Founder &...

BiotechTV - News ·

2026/07/27

He describes how science 'keeps you young' because it always based on what you don't know. He urges scientists to stay humble when talking about science to the public because things can change, and he shares stories from his career and offers advice on how to keep the United States globally competitive.

en-us

00:26:20

U.S. Science Summit: "Who will shape the future of...

BiotechTV - News ·

2026/07/23

Interviewed by HSBC Innovation Banking's Katherine Andersen, Najat Khan discusses AI, her priorities upon taking the role of CEO at Recursion earlier this year, encouraging employees to speak more than just one language of expertise, and women in leadership.

en-us

00:16:04

U.S. Science Summit: Three science communicator...

BiotechTV - News ·

2026/07/23

Moderated by BiotechTV's Chloe Kirk, Gabriel Astorga (@GoodOlGab), Maynard Okereke (@HipHopScienceShow), and Alex Dainis (@AlexDainis) describe how the got started posting about science on social media and how they grew their audiences to what they are today. Plus, advice for companies and scientists about how to resonate the best.

en-us

00:01:45

U.S. Science Summit: BiotechTV's Science...

BiotechTV - News ·

2026/07/23

The combined following of the group reaches approximately 3 million people on Instagram and TikTok.

en-us

00:07:41

U.S. Science Summit: Listen to BiotechTV founder Brad...

BiotechTV - News ·

2026/07/23

He describes the format and goals of the event.

en-us

00:30:17

U.S. Science Summit: Three leading biotech CEOs share...

BiotechTV - News ·

2026/07/22

Moderated by MassBio CEO Kendalle Burlin O'Connel, Kymera Therapeutics CEO Nello Mainolfi, CRISPR Therapeutics CEO Samarth Kulkarni, and Ginkgo Bioworks CEO Jason Kelly discuss their companies' innovations (protein degradation, CRISPR gene editing, and autonomous labs), how the U.S. can increase its competitiveness, and the 'Why' that motivates them each day.

en-us

00:18:35

U.S. Science Summit: Dr. Elias Zerhouni discusses the...

BiotechTV - News ·

2026/07/22

Dr. Zerhouni, the Founder and Chair of ModeX Therapeutics and Former NIH Director, talks about investments in science that started with Vannevar Bush, current day NIH funding, adding a political element to the grant making process, science communication, and more.

en-us

00:35:05

ASCO 2026: Fresh off an IPO, Eikon Therapeutics...

BiotechTV - News ·

2026/05/31

The lead two programs, which target TLR7/8 and PARP1, have data at ASCO and were licensed with the idea of laying the foundation for clinical expertise at Eikon. Another clinical program, a WRN helicase inhibitor, is the first to entirely come out of Eikon's platform. Plus, Dr. Perlmutter's take on being a public company, and his thoughts on China as a medicine cabinet to the world.

en-us

00:13:17

ASCO 2026: "The results that we presented from the...

BiotechTV - News ·

2026/05/31

Dr. Mark Goldsmith of Revolution Medicines describes the benefit seen by advanced patients who received the pancreatic cancer pill daraxonrasib vs those in a control group of investigator's choice standard-of-care chemotherapy, and he discusses the medicine's side effect profile. Plus, next steps for this treatment in pancreatic cancer and beyond.

en-us

00:16:57

London based Cytospire Therapeutics has announced an...

BiotechTV - News ·

2026/05/05

Co-Founder & CEO Natalie Mount discusses the raise, and explains why she believes gamma delta T-cell engagers have advantages over CD3s. After presenting preclinical data at the recent AACR annual meeting, the lead EGFR program is preparing to go into the clinic.

en-us

00:22:38

Replimune's Chairman discusses FDA's polarizing...

BiotechTV - News ·

2026/04/22

Philip Astley-Starke describes the timeline of development of this oncolytic immunotherapy, his impression of FDA's review process and decisions around it, and the status of where the treatment stands today.

en-us

00:22:37

Invivyd develops monoclonal antibodies to prevent or...

BiotechTV - News ·

2026/04/22

CSO Robert Allen describes Invivyd's approach and why antibodies can be a good approach, especially as it relates to being resistant to viral evolution. He walks us through the science and some potential use cases.

en-us

00:16:49

Bay Area based Epia Neuro exited stealth earlier this...

BiotechTV - News ·

2026/04/21

Co-Founder & CEO Michel Maharbiz describes the idea behind this brain-computer interface (BCI), which is not yet in human trials. While cautioning that much work and learning lies ahead, he sees the possibility that such a system could also improve a patient's rehab and might potentially have further uses in diseases of cognitive decline.

en-us

00:42:17

Peter Hotez discusses tropical disease, the...

BiotechTV - News ·

2026/04/21

He describes his work in tropical disease, and how climate change has been elevating it in areas like the Gulf Coast of the United States. Plus, the importance of elevating scientists, what he has found works best for communicating with the public, and why he disagrees with the idea of 'hunkering down' until a day that science funding might rebound in the U.S..

en-us

00:13:43

Physican and Biotech Investor Adam May reacts to this...

BiotechTV - News ·

2026/04/20

He shares his thoughts on the data, the competitive profile of this IL-2 Treg therapy vs JAK inhibitors, and how the overall platform looks for other I&I conditions.

en-us

00:14:05

10x Genomics today is announcing Atera, its new in...

BiotechTV - News ·

2026/04/19

Co-Founder and CEO Serge Saxonov walks us through the platform, which can process up to 800 whole-transcriptome samples per year (1 cm² each) on a single instrument, scaling to thousands of samples per year for targeted assays, and has single-cell level sensitivity.

en-us

00:25:57

Is this analyst the world's biggest bear on the...

BiotechTV - News ·

2026/04/17

Plus, discussions on key trial readouts outside of obesity: eplontersen, Lp(a), oral IL-23, and milvexian.

en-us

00:08:45

Raymond James Biotech Innovation Symposium: Biotech...

BiotechTV - News ·

2026/04/14

He discusses Praxis, Insmed, Ionis, PTC Therapeutics, Rapport, and United Therapeutics.

en-us

00:11:46

Raymond James Biotech Innovation Symposium: Korro Bio...

BiotechTV - News ·

2026/04/14

After experiencing a setback last year with Korro's LNP delivered alpha-1 antitrypsin deficiency program, he describes learnings from that experience and how Korro has new momentum with a galNAc delivered approach targeting urea cycle disorders, hepatic encephalophy, and new alpha-1 program. The company recently closed a $85 private placement.

en-us

485 results

Similar Podcasts

Planetterrian Daily

Patrick · Nerra Network

New Books in Science, Technology, and Society

New Books Network

Scifi Friday

Radio Memories Network

The Bio Report

Levine Media Group

Waterlines: How Water Shapes Our World

jaywen